Clinical Trial of BT02 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Interventions: Drug: BT02 monoclonal antibody injection Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | China Health | Clinical Trials | Hospitals | Research